ライフサイエンスコーパス: miconazole

1 which was completely blocked by SKF 525A and miconazole.

2 Miconazole 10(-6) mol/L or 17-octadecynoic acid 10(-5) m

3 Both 17-ODYA and miconazole (10(-5) mol/L, a chemically distinct P450 inh

4 zation, whereas clotrimazole (30 microM) and miconazole (15 microM) did not, and instead inhibited di

5 itories containing metronidazole 750 mg plus miconazole 200 mg or matching placebo for 5 consecutive

6 eived intravaginal metronidazole 750 mg plus miconazole 200 mg or placebo for 5 consecutive nights ea

7 ved intravaginal metronidazole (750 mg) plus miconazole (200 mg) or placebo for 5 consecutive nights

8 9.6+/-1.7% [control], 8.4+/-2.5% [0.96 mg/kg miconazole], 5.9+/-2.2% [0.28 mg/kg 17-ODYA], and 10.8+/

9 A once-daily miconazole 50 mg mucoadhesive buccal tablet (MBT) is a n

10 Miconazole, a nonselective inhibitor of cytochrome-P450

11 locked by ruthenium red, methanandamide, and miconazole, agents that inhibit the cation channel trans

12 Using measured volumes for nicardipine and miconazole aggregate particles (2.1 x 10(11) and 4.7 x 1

13 dazole, 1-phenylimidazole, clotrimazole, and miconazole all bound to the iNOSox monomer heme iron.

14 We previously showed that miconazole, an inhibitor of CYP2E1, blocks defluorinatio

15 NF preferentially bound to the membrane, and miconazole and bromocriptine preferentially bound to the

16 300 microM, in the presence of indomethacin, miconazole and BW755c) and the stable analogue of arachi

17 sins bound cationic antifungal drugs such as miconazole and chlorhexidine digluconate (CG) through io

18 Mechanistic studies show that miconazole and clobetasol function in oligodendrocyte pr

19 Two drugs, miconazole and clobetasol, are effective in promoting pr

20 our results provide a rationale for testing miconazole and clobetasol, or structurally modified deri

21 t agreement between methods was observed for miconazole and clotrimazole and for C. krusei isolates t

22 ntifungal agents with the exceptions only of miconazole and clotrimazole and of terconazole against C

23 When the data for miconazole and clotrimazole were removed from the analys

24 raconazole, and posaconazole) and topically (miconazole and clotrimazole) and by a tetrazole-based dr

25 Clotrimazole, econazole, miconazole and CN- also significantly inhibited intracel

26 Drugs such as miconazole and fenpropimorph that have different targets

27 However, equimolar intracerebellar doses of miconazole and forskolin (inhibitor and stimulator of ad

28 thanol's motor impairment by intracerebellar miconazole and forskolin, respectively.

29 While miconazole and sulconazole have intermediate activity ec

30 18F-FCWAY was almost completely inhibited by miconazole and, to a less extent, by diclofenac.

31 for TNS, 5.8 microm for ANF, 0.45 microm for miconazole, and 0.45 microm for bromocriptine.

32 A nonspecific CYP inhibitor, miconazole, and 2 specific CYPomega-hydroxylase inhibito

33 or flucytosine, 77% for terconazole, 66% for miconazole, and 53% for clotrimazole.

34 onic acid (TNS), alpha-naphthoflavone (ANF), miconazole, and bromocriptine) binding to CYP3A4 incorpo

35 he four imidazoles (econazole, clotrimazole, miconazole, and ketoconazole) were active: 94.3 to 98.5%

36 e, ketoconazole, itraconazole, clotrimazole, miconazole, and terconazole) and compared the results wi

37 inhibitor, AA861, the epoxygenase inhibitor, miconazole, and the cyclooxygenase inhibitor, indomethac

38 eatment with the cyctochrome P450 inhibitor, miconazole, blocked the formation of these products.

39 d concentrations of triclosan, triclocarban, miconazole, carbamazepine, and diphenhydramine in plant

40 was somewhat resistant to agents (SKF 96365, miconazole, clotrimazole, nitrendipine, and trifluoperaz

41 Three of these, miconazole, econazole, and sulconazole, were promiscuous

42 w that low doses of amiodarone and an azole (miconazole, fluconazole) are strongly synergistic and ex

43 Immune response assays show that miconazole functions directly as a remyelinating drug wi

44 ncentrations of triclosan, triclocarban, and miconazole in root and shoot tissue by two to three orde

45 essels, however, were eliminated by PPOH and miconazole, inhibitors of CYP/epoxygenase.

46 Cimetidine, diclofenac, and miconazole, known inhibitors of CYP450 2EI, were tested

47 The structurally unrelated EET ligands miconazole, MS-PPOH, and ketoconazole also inhibited the

48 In PET experiments, treatment of rats with miconazole nitrate (60 mg/kg intravenously) over the 45-

49 li, as well as effects of amphotericin-B and miconazole on S. cerevisiae through the device's time-de

50 eatment with intravaginal metronidazole plus miconazole reduced the proportion of visits with BV duri

51 ization, significant decreases were shown by miconazole-rifampicin (RR, 0.14 [95% CI, .05-.36]), 5-fl

52 The cytochrome P450 inhibitors, SKF 525A and miconazole, significantly attenuated these relaxations.

53 18F-FCWAY PET in miconazole-treated rats can serve as an effective platfo

54 The effects of miconazole treatment of rats on skull radioactivity upta

55 Miconazole treatment, by eliminating defluorination of 1

56 alf-life of radioligand was also extended by miconazole treatment.

57 ER stress generated in response to miconazole, tunicamycin, or other inhibitors also trigge

58 lanosterol, and the topical antifungal drug miconazole was the strongest inhibitor that we identifie

59 ytochrome P-450 inhibitors (clotrimazole and miconazole), we measured the carotid sinus nerve (CSN) d

60 that form large aggregates, nicardipine and miconazole, we measured particle numbers directly by flo

61 study, two commercial drugs, Loratadine and Miconazole, were identified as potential ligands for PFT

62 ant group of antifungals is the azoles (e.g. miconazole), which act by inhibiting lanosterol demethyl

63 le antimycotics, clotrimazole, econazole and miconazole, which are potent P450 inhibitors, significan

64 CYP130 also binds miconazole with virtually the same binding affinity as e